b'Of course, the unpredictable nature of this challenge presents opportunity, as Hill and her team push to find solutions involving changing the crosslinks of polymers and the materials themselves. These complexities define what makes this work unique and mean-ingfulentering uncharted waters to advance medicine. The hope is these challenges are overshadowed by the positive impacts of such breakthroughs. ADDRESSING BIAS IN CLINICAL TRIALSButala is no stranger to challenges technology brings in his work, either. Organizations and industries across the globe tapping into AI technology are dealing with a multitude of challenges, particularly ethical issues. The problem with AI is it basically can accen-tuate disparities or biases. In this context, could it be that doctors somehow under-report chest pain systems for women vs. men, or Black patients vs. white patients?Theres always a risk that there are subtle biases that, in the end, could exacerbate disparities, he said. Dr. Megan R. Hill, Ph.D.We are committed to:Better outcomes for our world Life-transforming technologiesInsight-driven careExperiences that put people firstEngineering the extraordinary2023 Medtronic. Medtronic, Medtronic logo, and Engineering the extraordinary are trademarks of Medtronic. All other brands are trademarks of a Medtronic company. UC202206943EN2023-2024 BIOSCIENCE COLORADO 33'